
Results
4
Big ticket companies showing a potential underpricing based on intrinsic value
4 companies
AstraZeneca
Market Cap: UK£182.1b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£120.36
7D
-8.4%
1Y
8.9%
GSK
Market Cap: UK£76.8b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK
UK£19.16
7D
-4.6%
1Y
39.5%
Haleon
Market Cap: UK£31.5b
Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.
HLN
UK£3.66
7D
-3.7%
1Y
5.1%
Hikma Pharmaceuticals
Market Cap: UK£3.3b
Develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products.
HIK
UK£15.71
7D
-3.6%
1Y
-16.6%